There is no evident and precise data regarding the effect of cholecystokinin octapeptide (CCK-OP) 
INTRODUCTION
Cholecystokinin (CCK) is one of the most important gastrointestinal hormones and exerts multiple physiological and pharmacological actions (Crawley and Corwin, 1994) . It is one of the major regulators of gastrointestinal motility (Thomson et al., 2003) . Its effect on small intestine motility is well established, at least in monogastric species, and its regulatory effect on peristalsis is included to the physiological actions of the hormone (Walsh, 1994) . The presence of specific CCK receptors creates the basis for these actions (Walsh, 1994; Miyasaka and Funakoshi, 2003) . However, the spectrum, character and mechanism of CCK effects have not been recognized in details. CCK is still the subject of extensive investigations (Dong et al., 2005 , Feltrin et al., 2004 . Thus, its expected effect upon the principal interdigestive motor pattern in the small bowel, i.e. the migrating motor or myoelectric complex (MMC) might be inhibitory.
The studies on dogs first indicated that CCK administration switches the gastrointestinal MMC into the irregular digestive pattern motor activity (Mukhopadhyay et al., 1977; Schang and Kelly, 1981) . Wingate et al. (1978a) showed that this effect was observed only in the proximal small intestine. In sheep, CCK also exerts its effects on gastrointestinal motility. These effects were demonstrated for CCK-peptides and for cerulein, the amphibian CCK analogue Praddaude, 1979, Ormas et al., 1984) . The inhibitory effect of CCK on MMC in ruminants was first suggested by Gregory but not documented (Cottrell and Gregory, 1991) . Further study showed that CCK antagonist L-364,718 could induce the premature phase 3 in ovine duodenum thus confirming indirectly the previous suggestion (Onaga et al., 1997) . The opposite effect after central administration of CCK antagonist was obtained by Kania et al (1999) . Thus, the aim of this study was to assess the precise effect of CCK-octapeptide (CCK-OP) on the MMC in the entire small intestine of conscious sheep.
MATERIALS AND METHODS
Five adult rams of Polish Merino Breed with individual body weight of 38-42 kg were used. Before surgery animals were fed with good-quality hay and were supplemented with a standard grain mixture. Drinking water was not limited.
Animal preparation
In 24 h fasted animals right lateral laparotomy was performed under general and local anesthesia as described previously (Romanski, 2003) . Seven electrodes were implanted onto the antral (one electrode), bulbar (one electrode), duodenal (one electrode), jejunal (two electrodes) and ileal (two electrodes) wall. The strain gauge force transducer was attached near the duodenal electrode. The marked wires were exteriorized and were connected with the recorder during the experiment.
Experiments
A total of 180 trials were performed. The scheme of the experiment was similar as previously published by Romanski (2002) . During the control recordings two normal consecutive phases 3 of the MMC were recorded. Then, CCK-OP was administered at doses of 0.02, 0.2 and 2.0 mg/kg of body weight during 30 (two lower doses) and 60 seconds (Romanski, 2004) into the jugular vein through the indwelling polyethylene catheter inserted before the experiment. The hormone was injected randomly during phase 1, 2a or 2b of the MMC identified in the duodenum. The myoelectric and motor recordings were continued until two consecutive phases 3 of the MMC were observed following drug administration. After the termination of the experiment the animals were sacrificed and the positions of the electrodes and of the transducer were confirmed.
Analysis of tracings and calculations
The recordings were visually analysed and MMCs and their phases were identified in the small intestine. The onset and duration of an activity front was estimated, as well as the duration of the whole pattern. The percentage of the activity fronts initiated on each segment of the small intestine was also calculated. The results of the duration of phase 3 MMC and of the whole MMC pattern underwent statistical analysis. For this purpose Student t-test for paired and unpaired values, where appropriate, followed by analysis of variance, was applied (Snedecor & Cochran, 1971) .
RESULTS
Duration of the MMC cycle in fasted animals did not vary significantly before and after CCK-OP administration except at the highest given dose during phase 2b of the MMC (Table 1) . When the hormone was introduced during phase 2a MMC, an increasing tendency was observed. A similar tendency was seen in nonfasted sheep after the moderate dose of CCK-OP was given during phase 2b MMC. When CCK was given during phase 2a MMC, it shortened the cycle duration significantly since in three of five sheep it induced the premature phase 3 of the MMC (Table 1 ). The highest dose of CCK offered during phase 2a or 2b MMC significantly elongated the MMC cycle.
The increase in MMC cycle duration in response to CCK administration was accompanied by inhibition of phase 3 MMC in the duodenum as the first phase 3 after the higher doses of CCK started usually from the jejunum ( Table 2 ). In spite of it, their occurrence was also delayed. These changes were similar in fasted and non-fasted sheep.
Duration of phase 3 in the jejunum also differed markedly depending on CCK dose both in fasted and non-fasted animals. After the higher CCK doses, phases 3 shortened in the jejunum significantly and a decresing tendency was observed (Table 3) .
First phase 3 of the MMC arriving after the highest dose of the hormone was often abnormal. It was found to be abortive, not fully developed, less regular or in two cases even retropropagated (Fig. 1) . 
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DISCUSSION
The obtained results indicate that CCK may inhibit phase 3 MMC and increase the cycle duration in fasted and non-fasted sheep. CCK-OP used in this study represents the form of CCK present in sheep tissue (Titchen, 1986) . Since OP-CCK does not cross the blood-brain barrier (Fioramonti and Bueno, 1988) , its effect following intravenous administration can be considered peripheral. The effect of CCK-OP on MMC cycle length was significant at higher doses. Similar results were obtained in dogs (Wingate et al., 1978a; Wingate et al., 1978b; Thor et al., 1990) . In sheep, except the suggestion of Gregory (Cottrell & Gregory, 1991) no such studies have been reported, thus the comparison of the doses cannot be made. However, it is known that in sheep the dose of CCK-OP 150 pmol/kg/h, (i.e. doses below 2 pmol/kg/30 s) is the maximal physiological dose (Zavros and Shulkes, 1997). The higher doses used in the present study, which produced significant changes in MMC cycle duration and inhibited phase 3 MMC in the duodenum were greater than the physiological dose suggested previously although the total amount of CCK-OP infusion was not markedly different. Thus, this action can probably be interpreted as pharmacological.
In the previous studies it was suggested that CCK, as the typical digestive hormone, can change the interdigestive myoelectric activity to a postprandial pattern (Lee et al., 1980) . However, the myoelectric activity following CCK not always resembled this pattern (Mukhopadhyay et al., 1977) . In sheep the postprandial pattern formerly does not occur since the MMC is not inhibited by feeding (Ruckebusch, 1989) . Even if some changes in myoelectrical activity occur after feeding, they are not precisely defined. Thus, it is difficult to state that in sheep CCK converts the interdigestive motor activity to the digestive pattern.
The inhibition of phase 3 MMC by CCK-OP administration was more efficient in the duodenum than in the jejunum. Though the distribution of CCK receptors along the small intestine is not well known in sheep it is possible that the mechanism of CCK action in the duodenum can be different than in the jejunum. In the dog the concentration of CCK receptors in the duodenum is high (Mantyh et al., 1994) . Furthermore, the concentration of small forms of CCK is greater in the upper small bowel (Walsh, 1994) . It has also been reported that the presence of this hormone in upper small intestine is greater than in the distal parts of the bowel (Bryant and Bloom, 1979) . The differences in the regulatory mechanism of CCK action in the small bowel can comprise it role in somatostatin release (Herzig et al., 1994; Zavros and Shulkes, 1997) . It is known that somatostatin can be responsible for the inhibition of phase 3 MMC in the duodenum (Walsh, 1994) . However, the small doses of CCK can be more active in the proximal jejunum than in the distal duodenum (Fleckenstein and Öigaard, 1977) . Thus, the exact mechanism of CCK action on small intestine motility is far from fully elucidated.
It is concluded that CCK may increase the MMC cycle duration in the small bowel and inhibits phase 3 of the MMC in the duodenum of fasted and non-fasted sheep.
